ERBB2 and breast carcinoma: We subsequently evaluated the status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), the most common biomarkers for breast cancer,[21, 34] and Ki‐67 on the organoids and matched tumors.